1. P317 Ustekinumab Trough Concentrations Associated with Biochemical Outcomes in Patients with Crohn's Disease. (21st January 2022) Authors: Straatmijer, T; Biemans, V B C; Moes, D J A R; Hoentjen, F; ter Heine, R; Maljaars, P W J; Theeuwen, R; Pierik, M; Duijvestein, M; van der Meulen, A E Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Population pharmacokinetics of ceftriaxone administered as continuous or intermittent infusion in critically ill patients. (4th March 2020) Authors: Leegwater, E; Kraaijenbrink, B V C; Moes, D J A R; Purmer, I M; Wilms, E B Journal: Journal of antimicrobial chemotherapy Issue: Volume 75:Number 6(2020) Page Start: 1554 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗